DE60133301D1 - Behandlungsverfahren mit wisp-polypeptiden - Google Patents

Behandlungsverfahren mit wisp-polypeptiden

Info

Publication number
DE60133301D1
DE60133301D1 DE60133301T DE60133301T DE60133301D1 DE 60133301 D1 DE60133301 D1 DE 60133301D1 DE 60133301 T DE60133301 T DE 60133301T DE 60133301 T DE60133301 T DE 60133301T DE 60133301 D1 DE60133301 D1 DE 60133301D1
Authority
DE
Germany
Prior art keywords
administration
cartilage
treatment
injury
repair
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60133301T
Other languages
English (en)
Other versions
DE60133301T2 (de
Inventor
Luc Desnoyer
Ellen H Filvaroff
Diane Pennica
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of DE60133301D1 publication Critical patent/DE60133301D1/de
Publication of DE60133301T2 publication Critical patent/DE60133301T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DE60133301T 2000-10-16 2001-10-12 Behandlungsverfahren mit wisp-polypeptiden Expired - Lifetime DE60133301T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24122200P 2000-10-16 2000-10-16
US241222P 2000-10-16
PCT/US2001/032142 WO2002033085A2 (en) 2000-10-16 2001-10-12 Wisp polypeptides and therapeutical applications thereof

Publications (2)

Publication Number Publication Date
DE60133301D1 true DE60133301D1 (de) 2008-04-30
DE60133301T2 DE60133301T2 (de) 2009-05-14

Family

ID=22909763

Family Applications (2)

Application Number Title Priority Date Filing Date
DE60133301T Expired - Lifetime DE60133301T2 (de) 2000-10-16 2001-10-12 Behandlungsverfahren mit wisp-polypeptiden
DE60141236T Expired - Lifetime DE60141236D1 (de) 2000-10-16 2001-10-12 Behandlungsverfahren unter Verwendung von WISP-Polypeptiden

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE60141236T Expired - Lifetime DE60141236D1 (de) 2000-10-16 2001-10-12 Behandlungsverfahren unter Verwendung von WISP-Polypeptiden

Country Status (10)

Country Link
US (2) US7687460B2 (de)
EP (3) EP1326980B1 (de)
JP (1) JP4202128B2 (de)
AT (3) ATE544855T1 (de)
AU (2) AU2437702A (de)
CA (1) CA2425145C (de)
DE (2) DE60133301T2 (de)
ES (3) ES2381935T3 (de)
IL (3) IL155279A0 (de)
WO (1) WO2002033085A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2381935T3 (es) * 2000-10-16 2012-06-01 Genentech, Inc. Polipéptidos WISP y sus aplicaciones terapéuticas
JP2007505131A (ja) * 2003-09-11 2007-03-08 ジェネンテック・インコーポレーテッド Ｗｉｓｐアンタゴニストの使用方法
SE0401069D0 (sv) 2004-04-26 2004-04-26 Anamar Medical Ab Use of Compounds for the Treatment of Diseases and Conditions
AU2007261530B2 (en) * 2006-06-20 2014-02-06 Genzyme Corporation Serum-free media and their uses for chondrocyte expansion
WO2008134054A1 (en) 2007-04-26 2008-11-06 Genera Doo Blood biomarkers for bone fracture and cartilage injury
EP2242764B1 (de) * 2008-01-18 2016-03-30 Burnham Institute for Medical Research Verfahren und zusammensetzungen in zusammenhang mit der internalisierung von rgd-peptiden
US10370245B2 (en) * 2009-06-22 2019-08-06 Sanford-Burnham Medical Research Institute Methods and compositions using peptides and proteins with C-terminal elements
SG177318A1 (en) 2009-07-14 2012-03-29 Scripps Research Inst Mesenchymal stem cell differentiation
WO2012104836A1 (en) * 2011-01-31 2012-08-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Snx9 as a novel biomarker for chronic inflammation and associated immunosuppression and a new regulator of t cell receptor expression and function
CN113398268A (zh) 2012-02-11 2021-09-17 霍夫曼-拉罗奇有限公司 R-spondin易位及其使用方法
UY35368A (es) 2013-03-08 2014-10-31 Irm Llc Péptidos y composiciones para el tratamiento de daño articular
MA38369B1 (fr) 2013-03-08 2018-10-31 Novartis Ag Peptides et compositions pour le traitement d'une lesion de l'articulation
CA3025960A1 (en) * 2016-06-02 2017-12-07 Nestec S.A. Methods for treating sarcopenia and muscle injury
AR116566A1 (es) 2018-10-03 2021-05-19 Novartis Ag Administración sostenida de polipéptidos similares a la angiopoyetina 3
KR102167443B1 (ko) * 2019-03-25 2020-10-19 주식회사 카티프라임 체외 골관절염 모델 및 이를 이용한 골관절염 치료제 스크리닝 방법
CN111700881B (zh) * 2020-07-02 2021-05-18 四川大学 Wnt蛋白＼ZIF-8纳米复合体、其制备方法及其应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364839A (en) 1990-06-18 1994-11-15 Genetics Institute, Inc. Osteoinductive pharmaceutical formulations
US5206023A (en) 1991-01-31 1993-04-27 Robert F. Shaw Method and compositions for the treatment and repair of defects or lesions in cartilage
US5408040A (en) 1991-08-30 1995-04-18 University Of South Florida Connective tissue growth factor(CTGF)
EP0736034A4 (de) 1993-12-22 1999-02-03 Merck & Co Inc Den wnt-x wachstumsfaktor kodierende dns
US5444047A (en) * 1994-06-16 1995-08-22 Dipasquale; Gene Treatment of arthritic and post-surgical orthopedic conditions with Insulin-like Growth Factor-I
ATE300554T1 (de) 1996-11-08 2005-08-15 Human Genome Sciences Inc Bindegewebe-wachstumsfaktor 3.
CA2294564A1 (en) * 1997-06-19 1998-12-23 Incyte Pharmaceuticals, Inc. Polynucleotides encoding a growth factor-like protein
US20020192209A1 (en) * 1997-09-17 2002-12-19 Genentech, Inc. Methods and compositions for inhibiting neoplastic cell growth
ES2313756T3 (es) 1997-10-29 2009-03-01 Genentech, Inc. Usos de polipeptido secretado wisp-1 inducido por wnt-1.
WO1999062927A1 (en) * 1998-06-05 1999-12-09 Human Genome Sciences, Inc. Connective tissue growth factor-4
AU2600800A (en) * 1999-03-08 2000-09-28 Genentech Inc. Promotion or inhibition of angiogenesis and cardiovascularization
KR100342045B1 (ko) * 1999-04-16 2002-06-27 김순택 2차전지
AU6088900A (en) 1999-07-23 2001-02-13 Case Western Reserve University Novel methods and reagents useful in the treatment of osteoarthritis
US20020063763A1 (en) * 2000-11-29 2002-05-30 Mantell David Allen Apparatus and method for removing air bubbles from an ink jet printhead
GB9930768D0 (en) * 1999-12-29 2000-02-16 Pfizer Ltd Composition
US6812339B1 (en) * 2000-09-08 2004-11-02 Applera Corporation Polymorphisms in known genes associated with human disease, methods of detection and uses thereof
ES2381935T3 (es) * 2000-10-16 2012-06-01 Genentech, Inc. Polipéptidos WISP y sus aplicaciones terapéuticas

Also Published As

Publication number Publication date
US7687460B2 (en) 2010-03-30
DE60133301T2 (de) 2009-05-14
ES2338492T3 (es) 2010-05-07
IL200484A0 (en) 2010-04-29
IL155279A0 (en) 2003-11-23
US20100093628A1 (en) 2010-04-15
EP1927659B1 (de) 2010-01-27
DE60141236D1 (de) 2010-03-18
IL155279A (en) 2011-05-31
JP2004534720A (ja) 2004-11-18
EP2180053B1 (de) 2012-02-08
WO2002033085A9 (en) 2002-07-25
ATE389719T1 (de) 2008-04-15
ES2304401T3 (es) 2008-10-16
AU2437702A (en) 2002-04-29
JP4202128B2 (ja) 2008-12-24
IL200484A (en) 2012-05-31
CA2425145C (en) 2011-08-30
EP1326980A2 (de) 2003-07-16
CA2425145A1 (en) 2002-04-25
WO2002033085A3 (en) 2003-04-17
EP2180053A3 (de) 2010-11-10
ATE544855T1 (de) 2012-02-15
AU2002224377B2 (en) 2007-07-19
AU2002224377B8 (en) 2002-04-29
US8138152B2 (en) 2012-03-20
EP1927659A1 (de) 2008-06-04
EP1326980B1 (de) 2008-03-19
ES2381935T3 (es) 2012-06-01
EP2180053A2 (de) 2010-04-28
WO2002033085A2 (en) 2002-04-25
ATE456655T1 (de) 2010-02-15
US20050054563A1 (en) 2005-03-10

Similar Documents

Publication Publication Date Title
IL200484A0 (en) Use of wisp polypeptides wisp for the preparation of medicaments
AU4935701A (en) Use of insulin for the treatment of cartilagenous disorders
DE69433742D1 (de) Bmp-10 zusammensetzungen
ATE362766T1 (de) Apolipoprotein a-i agonisten sowie deren verwendung zur behandlung dislipidemischer erkrankungen
DE69729125D1 (de) Troponin untereinheiten und fragmente zur verwendung als inhibitoren der angiogenese
DE69835810D1 (de) Osteogene vorrichtungen und verfahren zu ihrer verwendung zur knochenreparatur
DK1378572T3 (da) BMP-11-sammensætninger
ES2182902T3 (es) Sistema de reparacion de superficies de articulaciones.
ATE390142T1 (de) Synergistische zusammensetzung zur behandlung von diabetes mellitus
PT807633E (pt) Novas pirimidin-4-onas substituidas em 2,3, e fundidas com heteroarilo em (5,6)
EA200400734A1 (ru) Способ и композиция для потенциирования действия опиатного анальгетика
DE69821793D1 (de) Neuronale verwendungen des bmp-11
IT1293305B1 (it) Sali di acidi difosfonici e loro impiego farmacologico nel trattamento dell'osteoporosi
SE8902042L (sv) Treatment of arthritis
DE69808475D1 (de) Aminosäurederivate zur behandlung von schlaganfall
DK0918455T3 (da) Anvendelse af galanin til reparation af nerveskader

Legal Events

Date Code Title Description
8364 No opposition during term of opposition